Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$8.07 - $12.52 $762,615 - $1.18 Million
-94,500 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$8.57 - $15.79 $73,410 - $135,257
-8,566 Reduced 8.31%
94,500 $978,000
Q4 2020

Feb 02, 2021

SELL
$5.98 - $12.47 $11,960 - $24,940
-2,000 Reduced 1.9%
103,066 $860,000
Q3 2020

Nov 05, 2020

BUY
$4.65 - $8.73 $58,896 - $110,574
12,666 Added 13.71%
105,066 $647,000
Q2 2020

Aug 12, 2020

BUY
$4.66 - $8.7 $101,588 - $189,659
21,800 Added 30.88%
92,400 $770,000
Q1 2020

May 12, 2020

BUY
$5.05 - $15.01 $356,530 - $1.06 Million
70,600 New
70,600 $426,000

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $554M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.